Hexagon Nutrition IPO opens on June 5, 2026 and closes on June 9, 2026, with a price band of ₹42 to ₹45 per share. The issue is a ₹138.87 crore offer for sale, so the money from the IPO goes to existing shareholders rather than into the company’s balance sheet.
About Hexagon Nutrition
Hexagon Nutrition is a nutrition-focused company with a strong presence across the nutrition value chain. It operates in a space that benefits from rising health awareness, better nutrition adoption, and increasing demand for specialized food and wellness products.
Since the IPO is entirely an OFS, investors are buying into the business at a time when existing promoters are partly exiting their holdings. That makes it important to focus more on the company’s business quality, financials, and long-term prospects rather than only on where the issue proceeds will be used.
Hexagon Nutrition Key IPO details
Here are the main facts:
- IPO opens: June 5, 2026
- IPO closes: June 9, 2026
- Price band: ₹42 to ₹45 per share
- Issue size: ₹138.87 crore
- Issue type: Offer for Sale
- Lot size: 333 shares
- Minimum investment: ₹14,985 at the upper price band
- Allotment date: June 10, 2026
- Listing date: June 12, 2026
The IPO is listed on BSE and NSE, with NSE serving as the designated exchange. Anchor bidding took place a day earlier, on June 4, 2026.
Subscription Status
The Hexagon Nutrition IPO is subscribed 1.65 times on June 5, 2026 5:06:35 PM (Day 1). The public issue subscribed 2.43 times in the retail category, 0.00 times in the QIB category, and 2.03 times in the NII category.
Issue Reservation
Hexagon Nutrition IPO comprises a total issue size of 3,08,59,704 shares. Out of which, 1,54,29,852 (50.00%) are allocated to QIB, 46,28,956 (15.00%) allocated to NII 1,08,00,896 (35.00%) allocated to RII.
IPO Lot Size
Investors can bid for a minimum of 333 shares and in multiples thereof.
Company Financials (Restated Consolidated)
|
Period Ended |
31 Dec 2025 |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
327.60 |
261.36 |
250.54 |
288.90 |
|
|
275.57 |
331.29 |
304.62 |
281.65 |
|
|
27.03 |
24.38 |
12.21 |
5.82 |
|
|
37.55 |
40.07 |
24.88 |
17.17 |
|
|
223.05 |
195.60 |
176.29 |
163.84 |
|
|
210.92 |
183.89 |
164.51 |
152.30 |
|
|
39.79 |
26.60 |
36.89 |
51.87 |
|
|
Amount in ₹ Crore |
||||
Recently Listed IPOs in Pharmaceuticals & Biotechnology
|
Company |
Issue Type |
Issue Size |
Issue Price |
Listing Day Close |
Listing Gain/Loss % |
|
Mainboard |
₹408.79 Cr |
₹392 |
₹405.70 |
+3.49% |
|
|
Mainboard |
₹655.37 Cr |
₹1062 |
₹1,438.40 |
+35.44% |
|
|
Mainboard |
₹1,377.68 Cr |
₹485 |
₹628.20 |
+29.53% |
Objective of the IPO :-
-
Book Running Lead Managers’ fees and commission (including underwriting commission), brokerage and selling commission, as applicable
- Brokerage, commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage, and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs
- Fees payable to the Registrar to the Offer
- Others: Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses
- Printing and distribution of issue stationery
- Advertising and marketing expenses
- Fees payable to legal counsels
- Open A Free Demat Account TodayGet Started